Treatment Guides
Botox After GLP-1 Weight Loss: What to Know
Medically Reviewed by Emily Dawson, DHA, MBA, MSN, RN

Introduction
For many women, losing weight with a GLP-1 medication represents years of effort finally paying off. The scale moves, clothes fit differently, and energy improves. However, many experience an unexpected side effect: their face appears older.
This phenomenon is well-documented in clinical research. Researchers have termed it “Ozempic face,” describing the exaggerated facial volume loss that comes with rapid weight loss, resulting in an objectively more aged appearance. One study found that patients experiencing massive weight loss were rated as looking an average of 5.1 years older than their actual age.
Why Does Your Face Look Different?
As we age naturally, we lose facial fat and collagen that provide structural support. Weight loss accelerates this process. Common changes include more noticeable forehead lines, deeper periocular lines, hollow cheeks, reduced mid-face fullness, and an overall tired appearance.
The positive takeaway: you don’t have to choose between health improvements and facial confidence.
Can Botox Help?
Botox can address expression lines by relaxing the muscles that create them. It effectively treats forehead wrinkles, glabellar lines, and crow’s feet — lines that become more visible after weight loss due to reduced facial volume. Many patients report that Botox helps them look rested without appearing different to themselves or others.
What Botox Cannot Do
Botox is not designed to restore lost facial structure. If concerns include flatter cheeks, hollow eyes, or diminished facial softness, alternative treatments are necessary. Different concerns require different solutions.
Why a Combination Approach Often Works Best
Post-GLP-1 weight loss typically involves multiple facial changes, rarely addressable through single treatments.
A thoughtful plan may include:
- Botox: Softens movement-related wrinkles (forehead lines, frown lines, crow’s feet)
- Dermal fillers: Restores facial support and balance in hollowed or tired-appearing areas
- Medical-grade microneedling: Stimulates collagen production and improves skin texture
The objective is addressing facial concerns in layers — movement, structure, and skin quality — using a conservative approach that maintains a natural, rested appearance.
Why We’re Cautious About RF Microneedling After GLP-1 Weight Loss
Radiofrequency microneedling poses specific risks for GLP-1 patients. The treatment drives heat energy deep into the dermis and underlying fat. When facial fat is already depleted from weight loss, protective buffering tissue is compromised.
The FDA’s October 2025 safety communication reported that RF microneedling carries risks including burns, scarring, permanent fat loss, and nerve damage. On faces already volume-depleted, additional fat loss becomes more visible and consequential.
Providers should inquire about facial volume changes before recommending this treatment and adjust energy settings accordingly. If a provider doesn’t ask this question, patients should raise it themselves.
Is Botox Safe While Taking a GLP-1 Medication?
For most healthy patients, there are no known direct interactions between Botox and commonly prescribed GLP-1 medications like semaglutide or tirzepatide. However, a consultation remains important to evaluate overall health, current medications, and aesthetic goals.
Should You Wait Until You Finish Losing Weight?
Not necessarily. Botox can begin during active weight loss since it addresses expression lines unrelated to facial volume. Treatments restoring facial structure, such as fillers, are often easier to plan once weight stabilizes, as ongoing weight loss continues changing facial architecture. The best timing depends on individual goals and journey stage.
The Bottom Line
Weight loss should not diminish confidence in one’s reflection. While Botox may address some concerns post-GLP-1 therapy, it rarely provides complete solutions independently. Effective plans typically combine Botox, fillers, microneedling, or integrated approaches targeting skin quality, facial structure, and expression lines together. Aesthetic medicine should complement overall health, helping your reflection match the effort behind your transformation.
Sources
-
Daneshgaran, G., Shauly, O., & Gould, D. J. (2025). “Ozempic Face” in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions. Aesthetic Surgery Journal Open Forum. https://doi.org/10.1093/asjof/ojaf056
-
U.S. Food and Drug Administration. (2025, October 15). Safety Communication: Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling Devices. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/microneedling-devices
-
Interest in Facial Volume Restorative Procedures With the Rise in “Ozempic Face”: A Google Trends Analysis. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12622603/